Treatment of thrombotic thrombocytopenic purpura with rituximab. Report of eight cases
No Thumbnail Available
Date
2015
Journal Title
Journal ISSN
Volume Title
Publisher
SOC MEDICA SANTIAGO
Abstract
Thrombotic thrombocytopenic purpura, an immune/non-immune thrombotic microangiopathy (TTP/TMA) is associated with high morbidity and mortality, even with appropriate treatment. In patients refractory to standard treatment with plasmapheresis there is no certainty about the best therapeutic strategy. This report shows our experience in eight refractory patients who survived after treatment with rituximab.
Description
Keywords
Purpura, thrombotic thrombocytopenic, rituximab, Thrombotic microangiopathies